We are monitoring the impact of COVID-19 on MEA Sepsis Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2830
Share on
Share on

Middle East & Africa Sepsis Diagnostics Market Research Report – Segmented By Pathogen, Product , Technology, Method , Usability, & By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2830
Pages: 140

MEA Sepsis Diagnostics Market Size (2021 to 2026)

The size of the Middle East and Africa sepsis diagnostics market was worth USD 35.36 Million in 2021 and USD 52.05 Million by 2026, growing at a CAGR of 8.04% from 2021 to 2026.

A few of the factors accelerating the growth of the Middle East and Africa (MEA) sepsis diagnostic market are the increased prevalence of sepsis, the increased incidence of hospital-acquired infections, the increased number of cases of pneumonia, the increased number of septic surgeries, and research activities related to sepsis. Nosocomial infections (HAIs) are the most common complication among inpatients, producing an estimated 4.5 HAIs per 100 inpatients and costing $ 35-45 billion annually. These HAIs are also called nosocomial infections. According to the Centers for Disease Control and Prevention (CDC), nosocomial infections can occur in 1 in 20 treated patients. Nosocomial infections cause more than 99,000 deaths each year. The most common causes of nosocomial diseases include surgical, respiratory, urinary tract, and bloodstream infections. Healthcare providers, nursing teams, and individual physicians and nurses are also aware of infection-related issues and have taken specific steps to prevent them. Similar hospital infections have been observed around the world, increasing the demand for sepsis diagnosis. As a result, increased nosocomial infections are supposed to drive the overall growth of the sepsis diagnostics market in the MEA over the forecast period.

However, the lack of awareness and the skilled workforce in the Middle East and Africa region are some factors that restrain the growth of the sepsis diagnostic market in the area.

One disadvantage of this approach is that it cannot identify organisms that cannot be cultured. Also, after blood culture, molecular diagnostic techniques are considered standard pathogen identification techniques.

This research report segmented and sub-segmented the Asia Pacific Sepsis Diagnostics Market into the following categories:

By Pathogen:

  • Bacterial Sepsis    
    • Gram-Negative Bacterial Sepsis
    • Gram-Positive Bacterial Sepsis
  • Fungal Sepsis        
  • Other Pathogen Infections

By Product:

  • Instruments          
  • Blood Culture Media          
  • Assay Kits & Reagents       
  • Software  

By Technology:

  • Microbiology         
  • Molecular Diagnostics       
  • Immunoassays    
  • Flow Cytometry  
  • Other Technologies

By Method:

  • Conventional Diagnostics
  • Automated Diagnostics

By Usability:

  • Laboratory Testing              
  • Point-of-Care Testing

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The regional market is growing due to the growing elderly population in the region, the development of healthcare infrastructure, and increasing cancer and diabetes in countries such as UAE, Saudi Arabia, South Africa, and others. In addition, MEA Sepsis Diagnostics Market is emerging with economies that offer growth opportunities due to increased neonatal umbilical cord infections and the number of surgical procedures in this region. The newly developed test uses microelectrodes to analyze a patient's blood and achieve a final result in two and a half minutes. By developing and starting this advanced rapid test, critical players in the market have ample opportunities to strengthen their position in the local market.

KEY MARKET PLAYERS:

A few of the promising companies operating in the MEA sepsis diagnostics market profiled in the report are Biomérieux SA, T2 Biosystem Inc, Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc, Abbott Laboratories, Roche Diagnostics Limited, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Pathogen                    

                                5.1.1 Introduction           

                                5.1.2 Bacterial Sepsis     

                                                5.1.2.1 Gram-Negative Bacterial Sepsis

                                                5.1.2.2 Gram-Positive Bacterial Sepsis

                                5.1.3 Fungal Sepsis         

                                5.1.4 Other Pathogen Infections              

                                5.1.5  Y-o-Y Growth Analysis, By Pathogen           

                                5.1.6  Market Attractiveness Analysis, By Pathogen         

                                5.1.7  Market Share Analysis, By Pathogen          

                5.2 Product                        

                                5.2.1 Introduction           

                                5.2.2 Instruments           

                                5.2.3 Blood Culture Media           

                                5.2.4 Assay Kits & Reagents        

                                5.2.5 Software  

                                5.2.6 Y-o-Y Growth Analysis, By Product               

                                5.2.7 Market Attractiveness Analysis, By Product             

                                5.2.8 Market Share Analysis, By Product               

                5.3 Technology                 

                                5.3.1 Introduction           

                                5.3.2 Microbiology          

                                5.3.3 Molecular Diagnostics        

                                5.3.4 Immunoassays      

                                5.3.5 Flow Cytometry    

                                5.3.6 Other Technologies             

                                5.3.7 Y-o-Y Growth Analysis, By Technology        

                                5.3.8  Market Attractiveness Analysis, By Technology     

                                5.3.9  Market Share Analysis, By Technology       

                5.4 Method                       

                                5.4.1 Introduction           

                                5.4.2 Convential Diagnostics       

                                5.4.3 Automated Diagnostics     

                                5.4.4 Y-o-Y Growth Analysis, By Method               

                                5.4.5  Market Attractiveness Analysis, By Method            

                                5.4.6  Market Share Analysis, By Method             

                5.5 Usability                       

                                5.5.1 Introduction           

                                5.5.2 Laboratory Testing               

                                5.5.3 Point-of-Care Testing         

                                5.5.4 Y-o-Y Growth Analysis, By Usability              

                                5.5.5 Market Attractiveness Analysis, By Usability            

                                5.5.6 Market Share Analysis, By Usability              

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Pathogen

                                                6.1.3.3 By Product

                                                6.1.3.4 By Technology

                                                6.1.3.5 By Method

                                                6.1.3.6 By Usability

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Pathogen

                                                6.1.4.3 By Product

                                                6.1.4.4 By Technology

                                                6.1.4.5 By Method

                                                6.1.4.6 By Usability

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Pathogen

                                                6.1.5.3 By Product

                                                6.1.5.4 By Technology

                                                6.1.5.5 By Method

                                                6.1.5.6 By Usability

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 bioMérieux SA                          

                                8.1.1 Overview 

                                8.1.2 Pathogen Analysis               

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 T2 Biosystem Inc                      

                8.3 Cepheid                       

                8.4 Thermo Fisher Scientific Inc.                               

                8.5 Nanosphere Inc                        

                8.6 Abbott Laboratories                               

                8.7 Roche Diagnostics Limited                    

                8.8 Becton, Dickinson and Company                       

                8.9 Bruker Corporation                 

                8.10 Beckman Coulter, Inc                           

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  2. Middle East & Africa Bacterial Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  3. Middle East & Africa Fungal Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  4. Middle East & Africa Other Pathogen Infections Market By Region, From 2021 to 2026 (USD Million)
  5. Middle East & Africa Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  6. Middle East & Africa Instruments Market By Region, From 2021 to 2026 (USD Million)
  7. Middle East & Africa Blood Culture Media Market By Region, From 2021 to 2026 (USD Million)
  8. Middle East & Africa Assay Kits and Reagents Market By Region, From 2021 to 2026 (USD Million)
  9. Middle East & Africa Software Market By Region, From 2021 to 2026 (USD Million)
  10. Middle East & Africa Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  11. Middle East & Africa Molecular Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  12. Middle East & Africa Microbiology Market By Region, From 2021 to 2026 (USD Million)
  13. Middle East & Africa Immunoassay Market By Region, From 2021 to 2026 (USD Million)
  14. Middle East & Africa Flow Cytometry Market By Region, From 2021 to 2026 (USD Million)
  15. Middle East & Africa Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  16. Middle East & Africa Conventional Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  17. Middle East & Africa Automated Sepsis Diagnostics Market By Region, From 2021 to 2026 (USD Million)
  18. Middle East & Africa Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)
  19. Middle East & Africa Laboratory Testing Market By Region, From 2021 to 2026 (USD Million)
  20. Middle East & Africa Point-of-Care Testing Market By Region, From 2021 to 2026 (USD Million)
  21. Middle East Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  22. Middle East Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  23. Middle East Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  24. Middle East Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  25. Middle East Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)
  26. Africa Sepsis Diagnostics Market By Pathogen, From 2021 to 2026 (USD Million)
  27. Africa Sepsis Diagnostics Market By Products, From 2021 to 2026 (USD Million)
  28. Africa Sepsis Diagnostics Market By Technology, From 2021 to 2026 (USD Million)
  29. Africa Sepsis Diagnostics Market By Method, From 2021 to 2026 (USD Million)
  30. Africa Sepsis Diagnostics Market By Usability, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample